Craig Bijou

The U.S. IPO market was red-hot in 2021. The total number of traditional U.S. IPOs hit its highest level since the dot-com boom in the late 1990s, while total IPO deal value reached record levels last year. Unfortunately for investors, many of the most popular 2021 IPO stocks have...

Enabling tech is likely to continue driving Globus Medical Inc’s (NYSE: GMED) market share gains in 2022, according to BofA Securities. The Globus Medical Analyst: Craig Bijou upgraded the rating for Globus Medical from Underperform to Buy, while raising the price target from $55 to $80. The...

Robotic surgical system manufacturer Intuitive Surgical, Inc. (NASDAQ: ISRG) reported above-consensus second-quarter results Thursday.  The Analysts Canaccord Genuity analyst Jason Mills maintained a Buy rating on Intuitive Surgical and lifted the price target from $575 to $610. Stifel...

Spine stocks were steadied with supportive coverage from the Street this week.  The Ratings Cantor Fitzgerald analysts Craig Bijou and Jordan Abrams initiated coverage on: Globus Medical Inc (NYSE: GMED) with an Overweight rating and $65 price target; K2M Group Holdings Inc (NASDAQ:...